Esteem
Envoy Medical Corporation · Decision date May 21, 2026
What did the FDA approve?
FDA records P090018/S042 as a supplement to PMA P090018, with the supplement type “Real-Time Process”. The recorded decision is approval, dated May 21, 2026.
FDA approval order statement
Approval for a new laser reflector material used with Laser Doppler Vibrometer (LDV) measurements during the implantation procedure.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Ear, Nose, Throat
- Decision date
- May 21, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P090018/S042
- Regulatory pathway
- PMA supplement
- Applicant
- Envoy Medical Corporation
- Product code
- OAF
- Decision code
- APPR
- Decision date
- May 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implant, hearing, active, middle ear, totally implanted.
- Applicant
- Envoy Medical Corporation
- Product code
- OAF
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P090018. Subsequent supplements may change the device or its indications.
FDA decision timeline
P090018 · Original PMA
ESTEEM TOTALLY IMPLANTABLE HEARING SYSTEM
P090018/S042 received
Application receipt date recorded by FDA.
P090018/S042 · FDA decision
Real-Time Process
Timeline entries are records held by MedtechLedger for P090018. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P090018
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Envoy Medical Corporation | PMA approval | Mar 17, 2010 | FDA | |
EsteemP090018/S043 | Envoy Medical Corporation | PMA supplement | Jun 3, 2026 | FDA |
EsteemP090018/S044 | Envoy Medical Corporation | PMA supplement | Oct 15, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Envoy Medical Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 4875 White Bear Pkwy., White Bear Lake, MN, 55110
Sources and methodology
- Original FDA record: P090018/S042
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

